Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2012
03/13/2012US8133973 Immunogenic compositions for Chlamydia trachomatis
03/13/2012US8133972 IgE antigenic peptides
03/13/2012US8133917 Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isoform
03/13/2012US8133881 Carbohydrate conjugates to prevent abuse of controlled substances
03/13/2012US8133878 Methods for treating restenosis
03/13/2012US8133877 Composition comprising an antisense sequence implicated in the regulation of angiogenesis
03/13/2012US8133868 Dipeptides for prevention of muscle breakdown and microbial infection
03/13/2012US8133867 Method for treating rheumatoid arthritis with an antibody that binds to a hepatocyte growth factor receptor
03/13/2012US8133866 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
03/13/2012US8133865 Two polymer chains (especially polyethylene oxide) connected to each other through a fluorenedicarbamoylmethyl group, which in turn is connected to an amine active agent by a releasable carbamate linkage; increased in vivo half-life
03/13/2012US8133864 PAR-2 agonist
03/13/2012US8133863 Stabilizing alkylglycoside compositions and methods thereof
03/13/2012US8133862 Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency
03/13/2012US8133861 Systemic purine administration: modulating axonal outgrowth of central nervous system neurons
03/13/2012US8133860 Facilitation of resuscitation from cardiac arrest by erythropoietin
03/13/2012US8133859 SCGB3A2 as a growth factor and anti-apoptotic agent
03/13/2012US8133857 NOTCH inhibition in the treatment of atherosclerosis
03/13/2012US8133744 Production of antibodies and to medical uses involving antibodies
03/13/2012US8133691 Stable quantitation and detection of immune response levels with non-zero background peptides
03/13/2012US8133505 Transdermal delivery system for dried particulate or lyophilized medications
03/13/2012US8133498 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections
03/13/2012US8133490 Method and system to remove cytokine inhibitors in patients
03/13/2012US8133487 Soluble heterodimeric cytokine receptor
03/13/2012US8133486 Method and composition for altering a B cell mediated pathology
03/13/2012US8133484 Using bandage comprising aggregated gelatin and transglutaminase as covering for injured tissues
03/13/2012US8133483 Method of treating or preventing a disease or condition mediated by pathogenic IgG antibodies
03/13/2012US8133482 Activatable photodynamic therapy agents
03/13/2012US8133480 Cysteine variants of interleukin-11
03/13/2012US8133471 CLK-peptide and SLK-peptide
03/13/2012CA2671634C Ejection liquid and ejection method
03/13/2012CA2586056C Aryloxy-substituted benzimidazole derivative
03/13/2012CA2540529C Means and methods for the recruitment and identification of stem cells
03/13/2012CA2517452C Methods of detecting neurological disorders
03/13/2012CA2511995C Pharmaceutical preparations for treatments of diseases and disorders of the breast
03/13/2012CA2503130C Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens
03/13/2012CA2500236C Diagnosis of anorexia nervosa and bulimia nervosa using bdnf as a biological marker
03/13/2012CA2489227C Hla-a24-restricted cancer antigen peptides
03/13/2012CA2481586C Cheese capable of disinfecting helicobacter pylori
03/13/2012CA2474216C Control of gene expression using a complex of an oligonucleotide and a regulatory peptide
03/13/2012CA2467159C Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
03/13/2012CA2463358C Prolonged release biodegradable microspheres and method for preparing same
03/13/2012CA2459811C Modified peptides and their use for the treatment of autoimmune diseases
03/13/2012CA2442854C Hsa-free formulations of interferon-beta
03/13/2012CA2419607C Peptidomimetic protease inhibitors
03/13/2012CA2407238C The use of thymosin alpha 1 to reduce the side effects of chemotherapy in cancer patients
03/13/2012CA2402191C Use of insulin for the treatment of cartilagenous disorders
03/13/2012CA2388709C Gene upregulated in cancers of the prostate
03/13/2012CA2365898C Ibd-associated microbial antigens and methods of using same
03/13/2012CA2356779C Cytokine receptor chain
03/13/2012CA2347649C Mn gene and protein
03/13/2012CA2328140C Method of inhibiting osteoclast activity
03/13/2012CA2326959C Treatments for spinal muscular atrophy
03/13/2012CA2296272C Mammalian cytokine: interleukin-b30 and related reagents
03/13/2012CA2256308C Antibodies to the ed-b domain of fibronectin, their construction and uses
03/13/2012CA2250908C Combined use of gnrh agonist and antagonist
03/13/2012CA2238080C A novel haemopoietin receptor and genetic sequences encoding same
03/13/2012CA2216130C Process for the purification of glycoproteins like erythropoietin
03/13/2012CA2195955C Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/13/2012CA2191220C Cdna for human methylenetetrahydrofolate reductase
03/08/2012WO2012031296A2 Methods and composition for inhibiting or attenuating leukocyte-endothelial interactions
03/08/2012WO2012031258A1 Recombinant t-cell receptor ligands with covalently bound peptides
03/08/2012WO2012031250A2 Compositions for labeling nerves and methods of use
03/08/2012WO2012031240A2 Therapeutics for trauma induced factor v consumptive coagulopathy
03/08/2012WO2012031228A2 Llp2a-bisphosphonate conjugates for osteoporosis treatment
03/08/2012WO2012031115A2 In vivo anti-tumor activity of a recombinant il-7/hgf(beta) hybrid cytokine and associated methods of use
03/08/2012WO2012031103A2 Inhibitors of bcl-2
03/08/2012WO2012031069A1 Hair treatment composition with naturally - derived peptide identical to human hair
03/08/2012WO2012031023A2 Treatment of inflammatory bowel diseases using a tripeptide
03/08/2012WO2012030949A2 B2-glycoprotein i peptide inhibitors
03/08/2012WO2012030886A1 Combination of hdac inhibitors with thrombocytopenia drugs
03/08/2012WO2012030593A2 Methods and compositions for delivering interleukin-1 receptor antagonist
03/08/2012WO2012030535A2 Bacteriophage lytic enzymes as alternative antimicrobials
03/08/2012WO2012030302A1 Tyrosine-phosphorylated wbp2, a novel cancer target and biomarker
03/08/2012WO2012030231A1 Antifungal composition
03/08/2012WO2012030202A1 Process for obtaining a collagen-rich extract from animal skins and resulting extract
03/08/2012WO2012029958A1 Screening method for antidiabetic agent using newly identified insulin secretion regulation factor
03/08/2012WO2012029954A1 Process for production of novel degalactosylated gc globulin
03/08/2012WO2012029148A1 Freeze-dried recombinant human bone morphogenetic protein-2 preparation
03/08/2012WO2012029061A2 POLYPEPTIDES DERIVED FROM α-1 ANTITRYPSIN AND METHODS OF USE THEREOF
03/08/2012WO2012028959A1 Agonists of neurotrophin receptors and their use as medicaments
03/08/2012WO2012028556A1 Macrocyclic lactones and their use and their combinations with other active substances
03/08/2012WO2012028526A2 Tetranectin-apolipoprotein a-i, lipid particles containing it and its use
03/08/2012WO2012028525A2 Method for producing a lipid particle, the lipid particle itself and its use
03/08/2012WO2012028524A2 Method for producing a lipid particle, the lipid particle itself and its use
03/08/2012WO2012028479A1 Material combination for treating inflammatory or infectious diseases
03/08/2012WO2012028172A1 Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
03/08/2012WO2012028093A1 Use of g-csf dimer in the treatment of neutropenia
03/08/2012WO2012028089A1 Use of interleukin-22 in treating viral hepatitis
03/08/2012WO2012012300A3 Treatment of the adverse side-effects associated with administration of an anti-hyaluronan agent
03/08/2012WO2012010675A3 Bhlh proteins and their use as drugs
03/08/2012WO2012008860A3 Bacterial nitroreductase enzymes and methods relating thereto
03/08/2012WO2012007324A3 Stabilized factor viii variants
03/08/2012WO2012004678A3 Serine protease inhibitors
03/08/2012WO2012002986A3 Decellularized and delipidized extracellular matrix and methods of use
03/08/2012WO2012001149A3 Pharmaceutical compositions and methods for induction and enhancement of apoptosis in tumor cells
03/08/2012WO2011162989A3 Glp-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction
03/08/2012WO2011161427A3 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
03/08/2012WO2011156476A3 Insulin with a basal release profile
03/08/2012WO2011150393A9 Methods for improving maternal and fetal health
03/08/2012WO2011150190A3 Hcv inhibitor compounds and methods of use thereof
1 ... 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 ... 3163